Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-197
Lenacapavir Sodium
Cat. No.
AKA-197
CAS No.
2283356-12-5
MF
C39H32ClF10N7O5S2.Na
MW
991.28
Lenacapavir sodium is a first-in-class capsid protein inhibitor that binds at the interface between capsid hexamers and CA monomers, disrupting capsid assembly and viral maturation.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Lenacapavir Sodium
CAS No.
2283356-12-5
MF
C39H32ClF10N7O5S2.Na
MW
991.28
Specification
98%
Research Area
Anti-HIV
Description
Lenacapavir sodium is a first-in-class capsid protein inhibitor that binds at the interface between capsid hexamers and CA monomers, disrupting capsid assembly and viral maturation. Packing: 1kg/bag; 25kg/drum or as request Availability: API for research only, commercial supply only after the patent expires
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. De Clercq E, et al. Lenacapavir: A capsid inhibitor for HIV-1 treatment and prevention. Biochemical Pharmacology. 2025 Oct;240:117125.
[2]. Link JO, et al. Clinical targeting of HIV-1 capsid protein with a long-acting small molecule. Nature. 2020;584(7822):614-618.
[3]. Singh K, et al. GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds. Front Microbiol. 2019;10:1227.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
